전체메뉴

닫기
검색

ScienceON 논문 검색

  • home
  • ScienceON 논문 검색
search

검색어 : 통합검색[Vaughn Margaret]

총 196건 중 196건 출력

, 17/20 페이지

  • 161
    Use of Medications for Treating Anxiety or Depression among Testicular Cancer Survivors: A Multi-Institutional Study
    ArdeshirRouhaniFard, Shirin; Dinh, Paul C.; Monahan, Patrick O.; Fossa, Sophie D.; Huddart, Robert; Fung, Chunkit; Song, Yiqing; Feldman, Darren R.; Hamilton, Robert J.; Vaughn, David J.; Martin, Neil E.; Kollmannsberger, Christian; Einhorn, Lawrence; Kroenke, Kurt; Travis, Lois B.; Indiana University, Indianapolis, Indiana.; Indiana University, Indianapolis, Indiana.; Indiana University, Indianapolis, Indiana.; Oslo University Hospital, Oslo, Norway.; Royal Marsden Hospital, London, United Kingdom.; University of Rochester Medical Center, Rochester, New York.; Indiana University, Indianapolis, Indiana.; Memorial Sloan Kettering Cancer Center, New York, New York.; Princess Margaret Cancer Center, Toronto, Canada.; University of Pennsylvania, Philadelphia, Pennsylvania.; Dana-Farber Cancer Institute, Boston, Massachusetts.; University of British Columbia, Vancouver, British Columbia, Canada.; Indiana University, Indianapolis, Indiana.; Indiana University, Indianapolis, Indiana.; Indiana University, Indianapolis, Indiana.; (Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, v.30, 2021, pp.1129-1138)
  • 162
    A phase II trial of R115777, an oral farnesyl transferase inhibitor, in patients with advanced urothelial tract transitional cell carcinoma
    Rosenberg, Jonathan E.; von der Maase, Hans; Seigne, John D.; Mardiak, Jozef; Vaughn, David J.; Moore, Malcolm; Sahasrabudhe, Deepak; Palmer, Peter A.; Perez-Ruixo, Juan Jose; Small, Eric J.; Department of Medicine, University of California, San Francisco, California; Department of Oncology, Aarhus Kommune Hospital, Aarhus, Denmark; Department of Urology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire; Department of Medicine, Slovak National Cancer Institute, Bratislava, Slovak Republic; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Medicine and Pharmacology, Princess Margaret Hospital, Toronto, Ontario, Canada; Department of Medicine, University of Rochester, Rochester, New York; Johnson and Johnson Pharmaceutical Research and Development, Beerse, Belgium; Johnson and Johnson Pharmaceutical Research and Development, Beerse, Belgium; Department of Medicine, University of California, San Francisco, California; (Cancer, v.103, 2005, pp.2035-2041)
  • 163
    Clinical and Genome-Wide Analysis of Multiple Severe Cisplatin-Induced Neurotoxicities in Adult-Onset Cancer Survivors
    Trendowski, Matthew R.; Wheeler, Heather E.; El-Charif, Omar; Feldman, Darren R.; Hamilton, Robert J.; Vaughn, David J.; Fung, Chunkit; Kollmannsberger, Christian; Einhorn, Lawrence H.; Travis, Lois B.; Dolan, M. Eileen; Department of Medicine, University of Chicago, Chicago, Illinois.; Department of Biology and Program in Bioinformatics, Loyola University Chicago, Chicago, Illinois.; Department of Medicine, University of Chicago, Chicago, Illinois.; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; J.P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York.; Division of Medical Oncology, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Medical Oncology, Indiana University, Indianapolis, Indiana.; Department of Medical Oncology, Indiana University, Indianapolis, Indiana.; Department of Medicine, University of Chicago, Chicago, Illinois.; (Clinical Cancer research : an official journal of the American Association for Cancer Research, v.26, 2020, pp.6550-6558)
  • 164
    Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric Assessments
    Ardeshirrouhanifard, Shirin; Fossa, Sophie D.; Huddart, Robert; Monahan, Patrick O.; Fung, Chunkit; Song, Yiqing; Dolan, M. Eileen; Feldman, Darren R.; Hamilton, Robert J.; Vaughn, David; Martin, Neil E.; Kollmannsberger, Christian; Dinh, Paul; Einhorn, Lawrence; Frisina, Robert D.; Travis, Lois B.; Indiana University, Indianapolis, Indiana, USA; Oslo University Hospital, Oslo, Norway; Royal Marsden Hospital, London, United Kingdom; Indiana University, Indianapolis, Indiana, USA; University of Rochester Medical Center, Rochester, New York, USA; Indiana University, Indianapolis, Indiana, USA; University of Chicago, Chicago, Illinois, USA; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Princess Margaret Cancer Center, Toronto, Canada; University of Pennsylvania, Philadelphia, Pennsylvania, USA; Dana-Farber Cancer Institute, Boston, Massachusetts, USA; University of British Columbia, Vancouver, British Columbia, Canada; Indiana University, Indianapolis, Indiana, USA; Indiana University, Indianapolis, Indiana, USA; University of South Florida, Tampa, Florida, USA.; Indiana University, Indianapolis, Indiana, USA; (Ear and hearing, v.43, 2022, pp.794-807)
  • 165
    Psychotropic and stimulant medication (PSM) use among testicular cancer survivors (TCS): A multi-institutional clinical study of 680 patients given cisplatin-based chemotherapy (CHEM) (NCI 1R01 CA157823-02).
    Case-Eads, Somer; Travis, Lois B.; Fung, Chunkit; Sesso, Howard D.; Feldman, Darren R.; Vaughn, David J.; Hamilton, Robert James; Johnson, Eileen; Peterson, Derick R; Fossa, Sophie D.; Einhorn, Lawrence H.; Beard, Clair; Indiana University, Indianapolis, IN; University of Rochester School of Medicine and Dentistry, Rochester, NY; Wilmot Cancer Center, Rochester, NY; Division of Preventive Medicine, Harvard Medical School, Boston, MA; Memorial Sloan Kettering Cancer Center, New York, NY; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; University of Rochester School of Medicine and Dentistry, Rochester, NY; University of Rochester Medical Center, Rochester, NY; Oslo University Hospital, University of Oslo, Oslo, Norway; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.34, 2016, pp.242-242)
  • 166
    Estimation of 10-year (y) cardiovascular disease (CVD) risk after cisplatin-based chemotherapy (CBCT): A multi-institutional study of 459 germ cell tumor (GCT) survivors in the Platinum study.
    Feldman, Darren R.; Ardeshir-Rouhani-Fard, Shirin; Monahan, Patrick; Fung, Chunkit; Hamilton, Robert James; Vaughn, David J.; Beard, Clair; Oeffinger, Kevin C.; Einhorn, Lawrence H.; Fossa, Sophie D.; Sesso, Howard D.; Travis, Lois B.; Memorial Sloan Kettering Cancer Center, New York, NY; ; School of Public Health, Indiana University, Bloomington, IN; ; Indiana University School of Medicine, Indianapolis, IN; ; Wilmot Cancer Center, Rochester, NY; ; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; ; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; ; Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA; ; Memorial Sloan Kettering Cancer Center, New York, NY; ; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; ; Oslo University Hospital, University of Oslo, Oslo, Norway; ; Division of Preventive Medicine, Harvard Medical School, Boston, MA; ; Department of Medical Oncology, Indiana University, Indianapolis, IN; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.34, 2016, pp.10083-10083)
  • 167
    Cardiovascular disease (CVD) risk factors and health behaviors after cisplatin-based chemotherapy (CHEM): A multi-institutional study of testicular cancer survivors (TCS) in the Platinum study.
    Abu Zaid, Mohammad Issam; Fung, Chunkit; Williams, AnnaLynn; Sesso, Howard D.; Kerns, Sarah L.; Ardeshir-Rouhani-Fard, Shirin; Feldman, Darren R.; Hamilton, Robert James; Vaughn, David J.; Beard, Clair; Monahan, Patrick; Fossa, Sophie D.; Einhorn, Lawrence H.; Travis, Lois B.; Indiana University School of Medicine, Indianapolis, IN; ; Wilmot Cancer Center, Rochester, NY; ; University of Rochester School of Medicine and Dentistry, Rochester, NY; ; Division of Preventive Medicine, Harvard Medical School, Boston, MA; ; University of Rochester Medical Center, Rochester, NY; ; School of Public Health, Indiana University, Bloomington, IN; ; Memorial Sloan Kettering Cancer Center, New York, NY; ; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; ; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; ; Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA; ; Indiana University School of Medicine, Indianapolis, IN; ; Oslo University Hospital, University of Oslo, Oslo, Norway; ; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; ; Department of Medical Oncology, Indiana University, Indianapolis, IN; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.34, 2016, pp.10087-10087)
  • 168
    Cognitive function in long-term testicular cancer survivors: impact of modifiable factors
    Dinh Jr, Paul C; Monahan, Patrick O; Fung, Chunkit; Sesso, Howard D; Feldman, Darren R; Vaughn, David J; Hamilton, Robert J; Huddart, Robert; Martin, Neil E; Kollmannsberger, Christian; Althouse, Sandra; Einhorn, Lawrence H; Frisina, Robert; Root, James C; Ahles, Tim A; Travis, Lois B; Division of Medical Oncology, Indiana University School of Medicine , Indianapolis, IN,; Department of Biostatistics and Health Data Science, Indiana University , Indianapolis, IN,; J.P. Wilmot Cancer Institute, University of Rochester Medical Center , Rochester, NY,; Division of Preventive Medicine, Brigham and Women’s Hospital , Boston, MA,; Department of Medicine, Memorial Sloan Kettering Cancer Center , New York, NY,; Department of Medicine, University of Pennsylvania , Philadelphia, PA,; Department of Surgical Oncology, Princess Margaret Cancer Centre , Toronto, ON,; Division of Radiotherapy and Imaging, Institute of Cancer Research , London & Sutton,; Department of Radiation Oncology, Brigham and Women’s Hospital , Boston, MA,; Department of Medical Oncology, BC Cancer - Vancouver Centre , Vancouver, BC,; Department of Biostatistics and Health Data Science, Indiana University , Indianapolis, IN,; Division of Medical Oncology, Indiana University School of Medicine ,; (JNCI cancer spectrum, v.8, 2024, pp.pkae068)
  • 169
    Pharmacokinetic (PK) modeling of serum platinum to reveal extent of long-term exposure and associated comorbidities after cisplatin treatment.
    El Charif, Omar; Mu, Zepeng; Gamazon, Eric R; Dinh, Paul C; Ardeshirrouhanifard, Shirin; Monahan, Patrick O.; Feldman, Darren R.; Einhorn, Lawrence H.; Hamilton, Robert James; Vaughn, David J.; Martin, Neil E.; Fung, Chunkit; Fossa, Sophie D.; Travis, Lois B.; Dolan, M. Eileen; The University of Chicago, Chicago, IL; ; The University of Chicago, Chicago, IL; ; Vanderbilt University, Nashville, TN; ; Indiana University School of Medicine, Indianapolis, IN; ; Indiana University School of Medicine, Indianapolis, IN; ; Indiana University School of Medicine, Indianapolis, IN; ; Memorial Sloan Kettering Cancer Center, New York, NY; ; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; ; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; ; University of Pennsylvania, Philadelphia, PA; ; Dana-Farber Cancer Institute/ Brigham and Women's Hospital, Boston, MA; ; University of Rochester Medical Center, Rochester, NY; ; Oslo University Hospital, University of Oslo, Oslo, Norway; ; Indiana University School of Medicine, Indianapolis, IN; ; University of Chicago, Chicago, IL; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.36, 2018, pp.10058-10058)
  • 170
    Genome-wide association study of cisplatin-induced peripheral neuropathy (CIPN) in testicular cancer survivors.
    El Charif, Omar; Wheeler, Heather E.; Mushiroda, Taisei; Kubo, Michiaki; Gamazon, Eric R; Feldman, Darren R.; Hamilton, Robert James; Vaughn, David J.; Beard, Clair J.; Fung, Chunkit; Albany, Costantine; Johnson, Eileen; Fossa, Sophie; Cox, Nancy; Einhorn, Lawrence H.; Travis, Lois B.; Dolan, M. Eileen; University of Chicago, Chicago, IL; ; Departments of Biology and Computer Science, Loyola University Chicago, Chicago, IL; ; Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan; ; RIKEN Center for Integrative Medical Science, Yokohama, Japan; ; Vanderbilt University, Nashville, TN; ; Memorial Sloan Kettering Cancer Center, New York, NY; ; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; ; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; ; Harvard University, Boston, MA; ; Wilmot Cancer Center, Rochester, NY; ; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; ; University of Rochester School of Medicine and Dentistry, Rochester, NY; ; Oslo University Hospital, Oslo, Norway; ; Vanderbilt University, Nashville, TN; ; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; ; Department of Medical Oncology, Indiana University, Indianapolis, IN; ; ; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.34, 2016, pp.4543-4543)
맨앞이전페이지로1617181920

처음 오셨나요?